Edition:
India

Kalvista Pharmaceuticals Reports Fiscal Second Quarter Results


Friday, 14 Dec 2018 

Dec 14 (Reuters) - Kalvista Pharmaceuticals Inc ::KALVISTA PHARMACEUTICALS REPORTS FISCAL SECOND QUARTER RESULTS.KALVISTA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.22.KALVISTA PHARMACEUTICALS - KVD900 ENLARGED PHASE 2 TRIAL ON TRACK FOR POTENTIAL ON-DEMAND TREATMENT OF ATTACKS IN PATIENTS WITH HEREDITARY ANGIOEDEMA.KALVISTA PHARMACEUTICALS INC - INTRAVITREAL DIABETIC MACULAR EDEMA CANDIDATE KVD001 PHASE 2 TRIAL ENROLLMENT ON TRACK.KALVISTA PHARMACEUTICALS INC - OPERATIONS FUNDED INTO 2021.KALVISTA PHARMACEUTICALS INC - QTRLY REVENUE $5.6 MILLION VERSUS $1.1 MILLION. 

Company Quote

18.94
0.69 +3.78%
9:29pm IST